Catalyst Wire Dossier Catalyst Wire Dossier

CKD-506

· Chong Kun Dang Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKD-506, covering 2019-12-30 to 2019-12-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate [Phase 2]

See pricing